Tumor del estroma extragastrointestinal (EGIST) mesentéricoentidad rara con evolución atípica

  1. Beatriz Peláez-Lorenzo 1
  2. Carlos A Rodríguez Arias 2
  3. Luis Alberto Mata Juberías 3
  1. 1 Hospital Clínico Universitario de Valladolid Servicio de Oncología
  2. 2 Hospital Clínico Universitario de Valladolid Servicio de Neurocirugía
  3. 3 Hospital Universitario La Paz Servicio de Cirugía General
Show affiliations +
Journal:
Revista Colombiana de Cancerología

ISSN: 2346-0199,  0123-9015

Year of publication: 2016

Volume: 20

Issue: 2

Pages: 87-91

Type: Article

DOI: 10.1016/J.RCCAN.2015.11.004 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Revista Colombiana de Cancerología

Sustainable development goals

Abstract

Gastrointestinal stromal tumours (GIST) are the most common mesenchymal tumours of the gastrointestinal tract. Those GIST arising outside the gastrointestinal tract are called extra-gastrointestinal stromal tumours (EGIST) and share clinical, pathological and molecular features. They are very rare and very little is known about the correct management and prognosis of these neoplasms. The case is presented of a patient with a mesenteric EGIST and an unusual outcome. Its differential diagnosis is difficult, and the need for a multidisciplinary team approach is emphasised.

Bibliographic References

  • Miettinen, M,Lasota, J. (2001). Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 438. 1-12
  • Reith, JD,Goldblum, JR,Lyles, RH,Weiss, SW. (2000). Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 13. 577
  • Barros, A,Linhares, E,Valadão, M,Gonc¸alves, R,Vilhena, B,Gil, C. (2011). Extragastrointestinal stromal tumors (EGIST): a series of case reports. Hepatogastroenterology. 58. 865
  • Iqbal, N,Sharma, A,Iqbal, N. (2015). Clinicopathological and treatment analysis of 13 extragastrointestinal stromal tumors of mesentery and retroperitoneum. Ann Gastroenterol. 28. 105
  • Miettinen, M,Monihan, JM,Sarlomo-Rikala, M,Kovatich, AJ,Carr, NJ,Emory, TS. (1999). Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 23. 1109
  • Patnayak, R,Jena, A,Parthasarathy, S,Prasad, PD,Reddy, MK,Chowhan, AK. (2013). Primary extragastrointestinal stromal tumors: a clinicopathological and immunohistochemical study: a tertiary care center experience. Indian J Cancer. 50. 41
  • Llenas-García, J,Guerra-Vales, JM,Moreno, A,Ibarrola, C,Castelbon, FJ,Fernández-Ruiz, M. (2008). Primary extragastrointestinal stromal tumors in the omentum and mesentery: a clinicopathological and immunohistochemical study. Hepatogastroenterology. 55. 1002
  • Yi, JH,Park, BB,Kang, JH,Hwang, IG,Shin, DB,Sym, SJ. (2015). Retrospective analysis of extra-gastrointestinal stromal tumors. World J Gastroenterol. 21. 1845
  • Yamamoto, H,Oda, Y,Kawaguchi, K,Nakamura, N,Takahira, T,Tamiya, S. (2004). c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol. 28. 479
  • Gil-Arnaiz, I,Martínez-Trufero, J,Pazo-Cid, R,Felipo, F,Lecumberri, MJ,Calderero, V. (2009). Skull metastasis from rectal gastrointestinal stromal tumours. Clin Transl Oncol. 11. 625
  • Romero Rojas, AE,Mesa Botero, OA,Melo Uribe, MA,Chinchilla Olaya, SI,Barajas Solano, PA. (2011). Tumor del estroma gastrointestinal gástrico con metástasis inusual al cráneo. Rev Col Gastroenterol. 26. 311
  • (2010). Gastrointestinal Stromal Tumor Meta-Analysis Group (Meta-GIST) Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. J Clin Oncol. 28. 1247
  • Blanke, CD,Rankin, C,Demetri, GD,Ryan, CW,von Mehren, M,Benjamin, RS. (2008). hase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol. 26. 626
  • Poveda, A,del Muro, XG,López-Guerrero, JA,Martínez, V,Romero, I,Valverde, C. (2014). GEIS 2013 guidelines for gastrointestinal sarcomas (GIST). Cancer Chemother Pharmacol. 74. 883
Data source: Dialnet